Industry News
Pharmaceutical Industry News
Private Medicare Plans Misled Customers Into Signing Up, Senate Report Says
The report by Senate Democrats points to widespread misbehavior by the plans and the marketing firms they hire.
Indian Drugs, Sold Worldwide, Sometimes Deadly
Deaths believed to be linked to contaminated cough syrups in Gambia have brought attention to loose regulations in India and a lack of testing capacity in poor importing nations.
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The dual agreements would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on.
A Surge of Overseas Abortion Pills Blunted the Effects of State Abortion Bans
New data suggests that abortion has declined about 2 percent in the U.S. since the end of Roe, accounting for people who traveled across state lines or ordered pills online.
Covid Symptoms Can Rebound Even If You Don’t Take Paxlovid
A new study found that more than a third of those who recovered from an infection had symptoms recur days or weeks later.
Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Children
The side effect, a buildup of fluid in the brain, led to the death of one of the children and presents a grave setback for a class of personalized medicine.
Some Breast Cancer Patients Could Skip Surgery, Study Suggests
In a small trial, chemotherapy alone was sufficient to treat women with certain kinds of tumors.
As Midterms Near, Biden Warns Republicans Seek to Dismantle Democratic Legislation
The president also vowed to veto a federal abortion ban if Republicans regain control of Congress and seek to pass such legislation, in an interview with MSNBC.
Cough Syrup: What We Know About Tainted Medicine from India
Tainted syrup from India may be connected to the deaths of dozens of children in Gambia, officials said. Indonesia banned cough syrup sales, though the link there is unclear.
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
In use for 11 years, the drug Makena provided a test case of the agency’s controversial accelerated approval program. A post-market study showed the drug was not effective.
Biden Tries to Reassure Voters on Health Care Costs Before Election
At an event in Southern California, the president says his administration is working to keep costs down and warns that Republicans will drive prices higher if they gain power.
What A.L.S. and Alzheimer’s Drug Approvals Have in Common
Regulators must balance patient’s needs with their safety.
F.D.A. Confirms Widespread Shortages of Adderall
The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.
¿Las nuevas vacunas contra la malaria podrán erradicarla?
Dos nuevas vacunas finalmente pueden hacer retroceder al antiguo flagelo. Pero, de manera inesperada, su llegada también complica el camino para acabar con la enfermedad.
Can New Vaccines Finally Eradicate Malaria?
Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease.
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
The list price of the therapy, Relyvrio, is much higher than an economic research group recommends, but the company says most patients will pay very little themselves.
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?
Durante varios años ha existido en Sudáfrica una pastilla que se debe tomar todos los días para prevenir el virus. Ahora existe una inyección cada dos meses, un método mucho más accesible, pero aún no
FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Covid Boosters
Who should get a Covid booster, and when? We answer the big questions.